INVIVYD INC (IVVD) Fundamental Analysis & Valuation

NASDAQ:IVVD • US00534A1025

1.8 USD
+0.06 (+3.45%)
At close: Mar 6, 2026
1.82 USD
+0.02 (+1.11%)
After Hours: 3/6/2026, 8:27:38 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This IVVD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

IVVD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 519 industry peers in the Biotechnology industry. IVVD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IVVD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. IVVD Profitability Analysis

1.1 Basic Checks

  • IVVD had negative earnings in the past year.
  • IVVD had a negative operating cash flow in the past year.
  • In the past 5 years IVVD always reported negative net income.
  • IVVD had a negative operating cash flow in each of the past 5 years.
IVVD Yearly Net Income VS EBIT VS OCF VS FCFIVVD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -50M -100M -150M -200M

1.2 Ratios

  • IVVD has a Return On Assets (-43.02%) which is comparable to the rest of the industry.
  • IVVD has a Return On Equity of -64.32%. This is comparable to the rest of the industry: IVVD outperforms 58.00% of its industry peers.
Industry RankSector Rank
ROA -43.02%
ROE -64.32%
ROIC N/A
ROA(3y)-93.62%
ROA(5y)-74.61%
ROE(3y)-143.77%
ROE(5y)-106.92%
ROIC(3y)N/A
ROIC(5y)N/A
IVVD Yearly ROA, ROE, ROICIVVD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -50 -100 -150 -200 -250

1.3 Margins

  • The Gross Margin of IVVD (93.34%) is better than 94.22% of its industry peers.
  • IVVD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 93.34%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVVD Yearly Profit, Operating, Gross MarginsIVVD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. IVVD Health Analysis

2.1 Basic Checks

  • IVVD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IVVD has more shares outstanding
  • There is no outstanding debt for IVVD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IVVD Yearly Shares OutstandingIVVD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
IVVD Yearly Total Debt VS Total AssetsIVVD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • IVVD has an Altman-Z score of -3.44. This is a bad value and indicates that IVVD is not financially healthy and even has some risk of bankruptcy.
  • IVVD's Altman-Z score of -3.44 is in line compared to the rest of the industry. IVVD outperforms 44.32% of its industry peers.
  • There is no outstanding debt for IVVD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.44
ROIC/WACCN/A
WACC8.79%
IVVD Yearly LT Debt VS Equity VS FCFIVVD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • IVVD has a Current Ratio of 2.47. This indicates that IVVD is financially healthy and has no problem in meeting its short term obligations.
  • IVVD has a Current ratio of 2.47. This is in the lower half of the industry: IVVD underperforms 71.10% of its industry peers.
  • IVVD has a Quick Ratio of 2.47. This indicates that IVVD is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.47, IVVD is not doing good in the industry: 68.40% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.47
IVVD Yearly Current Assets VS Current LiabilitesIVVD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. IVVD Growth Analysis

3.1 Past

  • IVVD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 73.47%, which is quite impressive.
  • The Revenue has grown by 332.71% in the past year. This is a very strong growth!
EPS 1Y (TTM)73.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
Revenue 1Y (TTM)332.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%41.17%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.77% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 73.00% on average over the next years. This is a very strong growth
EPS Next Y73.3%
EPS Next 2Y35.74%
EPS Next 3Y23.16%
EPS Next 5Y16.77%
Revenue Next Year105.64%
Revenue Next 2Y125.16%
Revenue Next 3Y85.25%
Revenue Next 5Y73%

3.3 Evolution

IVVD Yearly Revenue VS EstimatesIVVD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
IVVD Yearly EPS VS EstimatesIVVD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. IVVD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IVVD. In the last year negative earnings were reported.
  • Also next year IVVD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVVD Price Earnings VS Forward Price EarningsIVVD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVVD Per share dataIVVD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IVVD's earnings are expected to grow with 23.16% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.74%
EPS Next 3Y23.16%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IVVD Dividend Analysis

5.1 Amount

  • IVVD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IVVD Fundamentals: All Metrics, Ratios and Statistics

INVIVYD INC

NASDAQ:IVVD (3/6/2026, 8:27:38 PM)

After market: 1.82 +0.02 (+1.11%)

1.8

+0.06 (+3.45%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-05
Earnings (Next)05-13
Inst Owners84.26%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change1.72%
Market Cap507.58M
Revenue(TTM)50.04M
Net Income(TTM)-59.86M
Analysts82
Price Target8.16 (353.33%)
Short Float %9.94%
Short Ratio6.67
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-188.9%
Min EPS beat(2)-404.27%
Max EPS beat(2)26.47%
EPS beat(4)2
Avg EPS beat(4)-183.34%
Min EPS beat(4)-404.27%
Max EPS beat(4)26.47%
EPS beat(8)3
Avg EPS beat(8)-102.17%
EPS beat(12)5
Avg EPS beat(12)-65.44%
EPS beat(16)8
Avg EPS beat(16)-45.89%
Revenue beat(2)0
Avg Revenue beat(2)-25.93%
Min Revenue beat(2)-50.11%
Max Revenue beat(2)-1.74%
Revenue beat(4)0
Avg Revenue beat(4)-29.95%
Min Revenue beat(4)-67.83%
Max Revenue beat(4)-0.13%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.6%
EPS NY rev (1m)0%
EPS NY rev (3m)3.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.14
P/FCF N/A
P/OCF N/A
P/B 5.45
P/tB 5.45
EV/EBITDA N/A
EPS(TTM)-0.52
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.18
BVpS0.33
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -43.02%
ROE -64.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 93.34%
FCFM N/A
ROA(3y)-93.62%
ROA(5y)-74.61%
ROE(3y)-143.77%
ROE(5y)-106.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 31.58%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.47
Quick Ratio 2.47
Altman-Z -3.44
F-Score5
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)1470.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.24%
EPS Next Y73.3%
EPS Next 2Y35.74%
EPS Next 3Y23.16%
EPS Next 5Y16.77%
Revenue 1Y (TTM)332.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%41.17%
Revenue Next Year105.64%
Revenue Next 2Y125.16%
Revenue Next 3Y85.25%
Revenue Next 5Y73%
EBIT growth 1Y73.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year69.67%
EBIT Next 3Y15.8%
EBIT Next 5Y26.49%
FCF growth 1Y50.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.23%
OCF growth 3YN/A
OCF growth 5YN/A

INVIVYD INC / IVVD FAQ

What is the fundamental rating for IVVD stock?

ChartMill assigns a fundamental rating of 3 / 10 to IVVD.


What is the valuation status for IVVD stock?

ChartMill assigns a valuation rating of 1 / 10 to INVIVYD INC (IVVD). This can be considered as Overvalued.


How profitable is INVIVYD INC (IVVD) stock?

INVIVYD INC (IVVD) has a profitability rating of 1 / 10.


Can you provide the financial health for IVVD stock?

The financial health rating of INVIVYD INC (IVVD) is 6 / 10.